Product NDC: | 68180-611 |
Proprietary Name: | CEFTRIAXONE |
Non Proprietary Name: | CEFTRIAXONE |
Active Ingredient(s): | 250 mg/1 & nbsp; CEFTRIAXONE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68180-611 |
Labeler Name: | LUPIN PHARMACEUTICALS INC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065125 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030930 |
Package NDC: | 68180-611-10 |
Package Description: | 10 INJECTION, POWDER, FOR SOLUTION in 1 BOX (68180-611-10) |
NDC Code | 68180-611-10 |
Proprietary Name | CEFTRIAXONE |
Package Description | 10 INJECTION, POWDER, FOR SOLUTION in 1 BOX (68180-611-10) |
Product NDC | 68180-611 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CEFTRIAXONE |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20030930 |
Marketing Category Name | ANDA |
Labeler Name | LUPIN PHARMACEUTICALS INC |
Substance Name | CEFTRIAXONE SODIUM |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |